Recently, several states, including Delhi, have reported a rise in the number of black fungus cases among people recovering from COVID-19.
"For the black fungus (cases), the Delhi government will take all the steps and precautions necessary," Kejriwal said in a statement.
In an advisory released on May 9, the Centre had said that mucormycosis may turn fatal if it is not taken care of. The fungal infection mainly affects people who are on medication that reduces their ability to fight environmental pathogens.
Dr Ajay Swaroop, chairman of the ENT department at Sir Ganga Ram Hospital here, said the use of steroids in the treatment of COVID-19 coupled with the fact that many coronavirus patients have diabetes could be one of the reasons for the rise in the number of black fungus cases again.
He said the infection is commonly seen in patients who have recovered from COVID-19 but have comorbidities such as diabetes, kidney or heart failure, or cancer.